
Malignant pleural mesothelioma: an update
2021; Sociedade Brasileira de Pneumologia e Tisiologia; Linguagem: Inglês
10.36416/1806-3756/e20210129
ISSN1806-3756
AutoresGlaucia N. M. Hajj, Carolina Harumi Cavarson, Clóvis Antônio Lopes Pinto, Gabriela Venturi, João R. Navarro, Vladmir Cláudio Cordeiro de Lima,
Tópico(s)Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
ResumoMalignant mesotheliomas are rare types of cancers that affect the mesothelial surfaces, usually the pleura and peritoneum. They are associated with asbestos exposure, but due to a latency period of more than 30 years and difficult diagnosis, most cases are not detected until they reach advanced stages. Treatment options for this tumor type are very limited and survival ranges from 12 to 36 months. This review discusses the molecular physiopathology, current diagnosis, and latest therapeutic options for this disease.
Referência(s)